Curcumin and Metformin Nanoparticles for Diabetes Treatment
Author Information
Author(s): Sun Siwei, Hou Xinyi, Li Ke, Huang Chenqi, Rong Yu, Bi Jiao, Li Xueping, Wu Daocheng, Alvarez-Lorenzo Carmen, Rossi Filippo
Primary Institution: Xi’an Medical University
Hypothesis
Can curcumin and metformin be combined in nanoparticles to improve diabetes treatment in mice?
Conclusion
The study found that the combination of curcumin and metformin in nanoparticles significantly reduced blood glucose levels in diabetic mice.
Supporting Evidence
- The nanoparticles showed a high drug encapsulation rate of 100%.
- Blood glucose levels in diabetic mice were reduced to 6.7 ± 0.65 mmol/L after treatment.
- The study demonstrated the absence of in vivo and in vitro toxicity for the nanoparticles.
Takeaway
Researchers made tiny particles using curcumin and metformin to help treat diabetes in mice, and it worked really well to lower their blood sugar.
Methodology
The study used a combination of in vitro and in vivo experiments, including toxicity tests and blood glucose measurements in diabetic mice.
Limitations
The study was conducted only on mice, and further research is needed to confirm the findings in humans.
Participant Demographics
C57 mice, specific-pathogen-free grade, approximately 25 g each.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website